Exelixis
EXEL
#1638
Rank
โ‚ฌ10.07 B
Marketcap
35,29ย โ‚ฌ
Share price
-0.47%
Change (1 day)
70.34%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: โ‚ฌ10.07 Billion

As of January 2025 Exelixis has a market cap of โ‚ฌ10.07 Billion. This makes Exelixis the world's 1638th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ10.07 B8.62%
2024โ‚ฌ9.27 B37.49%
2023โ‚ฌ6.74 B39.91%
2022โ‚ฌ4.82 B-5.56%
2021โ‚ฌ5.10 B0.88%
2020โ‚ฌ5.06 B5.92%
2019โ‚ฌ4.77 B-7.31%
2018โ‚ฌ5.15 B-31.21%
2017โ‚ฌ7.49 B82.4%
2016โ‚ฌ4.10 B249.5%
2015โ‚ฌ1.17 B406.97%
2014โ‚ฌ0.23 B-71.68%
2013โ‚ฌ0.81 B29.06%
2012โ‚ฌ0.63 B28.4%
2011โ‚ฌ0.49 B-26.73%
2010โ‚ฌ0.67 B21.51%
2009โ‚ฌ0.55 B46.4%
2008โ‚ฌ0.37 B-38.75%
2007โ‚ฌ0.61 B-5.44%
2006โ‚ฌ0.65 B-1.28%
2005โ‚ฌ0.66 B26.28%
2004โ‚ฌ0.52 B31.56%
2003โ‚ฌ0.39 B-12.16%
2002โ‚ฌ0.45 B-56.99%
2001โ‚ฌ1.05 B45.65%
2000โ‚ฌ0.72 B

End of Day market cap according to different sources

On Jan 16th, 2025 the market cap of Exelixis was reported to be:

โ‚ฌ10.12 Billion
by Nasdaq info icon info icon
โ‚ฌ10.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚ฌ66.00 B 554.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ123.33 B 1,123.74%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ242.84 B 2,309.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ110.82 B 999.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ141.18 B 1,300.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ344.15 B 3,314.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ145.08 B 1,339.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ27.43 M-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.50 B-94.98%๐Ÿ‡บ๐Ÿ‡ธ USA